Fargiano Antonio A, Desai Kartiki V, Green Jeffrey E
Transgenic Oncogenesis Group, Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892, USA.
J Mammary Gland Biol Neoplasia. 2003 Jul;8(3):321-34. doi: 10.1023/b:jomg.0000010032.05234.6f.
Numerous mouse models for mammary cancer have been developed and characterized based upon their biological, molecular, and histopathological features. In an effort to dissect the molecular anatomy of such models and compare their gene expression profiles to those of human breast cancer, six models representing various oncogenic pathways have been investigated using cDNA microarray technology. Results of these analyses are presented and discussed in the context of technological challenges presented by analyzing data on such a large scale. Further expression profiling coupled with emerging proteomic technologies will more completely define and distinguish mouse models of mammary cancer from each other and provide a comprehensive basis for comparing such models with the human disease they are intended to represent.
基于其生物学、分子和组织病理学特征,已经开发并表征了许多乳腺癌小鼠模型。为了剖析这些模型的分子结构,并将它们的基因表达谱与人类乳腺癌的基因表达谱进行比较,已经使用cDNA微阵列技术研究了代表各种致癌途径的六个模型。这些分析的结果将在大规模分析数据所带来的技术挑战的背景下进行展示和讨论。进一步的表达谱分析与新兴的蛋白质组学技术相结合,将更全面地定义和区分乳腺癌小鼠模型,并为将这些模型与它们旨在代表的人类疾病进行比较提供全面的基础。